Theradiag S.A. buy krebskrebs
Start price
16.08.21
/
50%
€1.90
Target price
16.08.22
€2.40
Performance (%)
-14.53%
End price
17.08.22
€1.62
Summary
This prediction ended on 17.08.22 with a price of €1.62. The prediction for Theradiag S.A. disappointed with a performance of -14.53%. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Theradiag S.A. | - | - | - | - |
| iShares Core DAX® | 0.795% | 1.458% | 17.980% | 69.888% |
| iShares Nasdaq 100 | -3.088% | -0.762% | 3.169% | 101.814% |
| iShares Nikkei 225® | -0.952% | -2.268% | 12.208% | 45.300% |
| iShares S&P 500 | -1.393% | 0.199% | 1.698% | 63.763% |
Comments by krebskrebs for this prediction
In the thread Theradiag S.A. diskutieren
In the thread Trading Theradiag S.A.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten